NO20065196L - Terapeutisk kombinasjon for behandling av Alzheimers sykdom - Google Patents

Terapeutisk kombinasjon for behandling av Alzheimers sykdom

Info

Publication number
NO20065196L
NO20065196L NO20065196A NO20065196A NO20065196L NO 20065196 L NO20065196 L NO 20065196L NO 20065196 A NO20065196 A NO 20065196A NO 20065196 A NO20065196 A NO 20065196A NO 20065196 L NO20065196 L NO 20065196L
Authority
NO
Norway
Prior art keywords
disease
alzheimer
treatment
therapeutic combination
treating alzheimer
Prior art date
Application number
NO20065196A
Other languages
English (en)
Inventor
Gregg H Larson
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20065196L publication Critical patent/NO20065196L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Farmasøytiske sammensetninger som er nyttige for å behandle Alzheimers sykdom blir utgreiet. Fremgangsmåter for å behandle Alzheimers sykdom blir også utgreiet.
NO20065196A 2004-04-14 2006-11-13 Terapeutisk kombinasjon for behandling av Alzheimers sykdom NO20065196L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56214104P 2004-04-14 2004-04-14
PCT/IB2005/000923 WO2005099823A1 (en) 2004-04-14 2005-04-04 Therapeutic combination for treatment of alzheimers disease

Publications (1)

Publication Number Publication Date
NO20065196L true NO20065196L (no) 2007-01-03

Family

ID=34963723

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065196A NO20065196L (no) 2004-04-14 2006-11-13 Terapeutisk kombinasjon for behandling av Alzheimers sykdom

Country Status (14)

Country Link
EP (1) EP1737539A1 (no)
JP (1) JP2007532624A (no)
KR (1) KR20060133008A (no)
CN (1) CN1960781A (no)
AU (1) AU2005232447A1 (no)
BR (1) BRPI0509881A (no)
CA (1) CA2562069A1 (no)
IL (1) IL178120A0 (no)
MX (1) MXPA06011969A (no)
NO (1) NO20065196L (no)
RU (1) RU2006136361A (no)
TW (1) TW200533341A (no)
WO (1) WO2005099823A1 (no)
ZA (1) ZA200608239B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI432195B (zh) 2007-10-03 2014-04-01 Kowa Co 神經細胞死亡抑制劑
LT3413870T (lt) * 2016-02-11 2021-11-10 Sigmathera Sas Igmesinas, skirtas panaudoti alzheimerio ligos gydymui
EP3982956A4 (en) * 2019-06-14 2023-05-03 Joshua O. Atiba TRIPLE PHARMACEUTICAL COMPOSITION FOR PROTEIN INFECTIONS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028826A1 (en) * 2000-06-15 2002-03-07 Robl Jeffrey A. HMG-CoA reductase inhibitors and method
JP2005525391A (ja) * 2002-04-02 2005-08-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 認識維持の強化のためのスタチン治療
AU2003298514A1 (en) * 2002-05-17 2004-05-04 Eisai Co., Ltd. Methods and compositions using cholinesterase inhibitors
EP1585520A1 (en) * 2002-12-24 2005-10-19 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
WO2004082706A2 (en) * 2003-03-19 2004-09-30 Ares Trading S.A. Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders
US20050090449A1 (en) * 2003-05-13 2005-04-28 Boehringer Ingelheim International Gmbh Novel statine derivatives for the treatment of Alzheimer's disease

Also Published As

Publication number Publication date
BRPI0509881A (pt) 2007-10-16
KR20060133008A (ko) 2006-12-22
TW200533341A (en) 2005-10-16
IL178120A0 (en) 2006-12-31
ZA200608239B (en) 2008-06-25
MXPA06011969A (es) 2006-12-15
CA2562069A1 (en) 2005-10-27
RU2006136361A (ru) 2008-04-20
EP1737539A1 (en) 2007-01-03
JP2007532624A (ja) 2007-11-15
CN1960781A (zh) 2007-05-09
AU2005232447A1 (en) 2005-10-27
WO2005099823A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
FR16C0021I2 (fr) Azetidines en tant qu'inhibiteurs de mek et leur utilisation pour le traitement des maladies proliferatives
ATE475650T1 (de) Positive allosterische chinolon-m1- rezeptormodulatoren
EA200901373A1 (ru) Аминогетероциклические соединения
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
ATE530544T1 (de) Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren
EP1562897A4 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
GB0318447D0 (en) Therapeutic agents
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
GB0223040D0 (en) Therapeutic compounds
EA200801481A1 (ru) 5-(арилсульфонил)пиразолопиперидины
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
ATE507204T1 (de) Isoindolin-verbindungen und deren verwendungen
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
NO20081421L (no) Midler for hindring og behandling av forstyrrelser som involverer modulering av RYR-reseptorer
EP1673078A4 (en) BENZYL ETHER AND BENZYLAMINO BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
NO20084362L (no) Difenylazetidinon derivater inneholdende kolesterol absorbsjonsinhibitor aktivitet
WO2007016338A3 (en) Use of chk2 kinase inhibitors for cancer treatment
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
ATE409480T1 (de) Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
EA200600071A1 (ru) Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором
TW200732304A (en) Piperidine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application